内镜下扩张治疗儿童腐蚀性食管狭窄时辅助局部应用丝裂霉素C:随机对照试验的系统评价与荟萃分析。
完整摘要 · 中文译文
目的:腐蚀性食管狭窄是儿童吞咽困难需反复扩张的主要原因。我们评估了辅助局部应用丝裂霉素C(MMC)是否能改善儿童吞咽困难缓解率并减少扩张次数。 方法:我们检索了PubMed、Embase和Cochrane CENTRAL(自建库至2026年5月17日),纳入比较扩张联合局部MMC与单纯扩张治疗儿童腐蚀性食管狭窄的随机对照试验。采用RoB 2评估偏倚风险,采用GRADE评估证据确定性。进行随机效应荟萃分析;唯一符合纳入标准的成人RCT以叙述性方式报告。 结果:共汇总3项儿科RCT(221例患者;110例MMC,111例对照)。MMC与更高的吞咽困难缓解几率相关(OR 7.82;95% CI 4.17-14.65;I²=0%),且扩张次数更少(MD - 3.01;95% CI - 3.30至- 2.73;k = 2;I²=0%)。在110例汇总MMC暴露中,或包括非汇总对照证据的128例暴露中,均未发生可归因于MMC的不良事件。敏感性分析中效应稳健(OR 6.86;95% CI 3.34-14.10)。 结论:在儿童腐蚀性食管狭窄中,辅助局部应用MMC可改善吞咽困难缓解并减少扩张负担。仍需开展随访时间更长的多中心RCT。 PROSPERO注册号:CRD420261351544。
完整摘要 · 英文原文
PURPOSE: Caustic esophageal stricture is a major cause of pediatric dysphagia requiring repeated dilation. We assessed whether adjunctive topical mitomycin C (MMC) improves dysphagia resolution and reduces dilation sessions in children. METHODS: We searched PubMed, Embase, and Cochrane CENTRAL (inception through May 17, 2026) for randomized controlled trials comparing dilation plus topical MMC with dilation alone in children with caustic esophageal stricture. Risk of bias was assessed with RoB 2 and certainty with GRADE. Random-effects meta-analyses were performed; the single eligible adult RCT was reported narratively. RESULTS: Three pediatric RCTs (221 patients; 110 MMC, 111 control) were pooled. MMC was associated with higher odds of dysphagia resolution (OR 7.82; 95% CI 4.17-14.65; I²=0%), and fewer dilation sessions (MD - 3.01; 95% CI - 3.30 to - 2.73; k = 2; I²=0%). No MMC-attributable adverse events occurred across 110 pooled MMC exposures, or 128 including non-pooled controlled evidence. Effects were robust in sensitivity analysis (OR 6.86; 95% CI 3.34-14.10). CONCLUSION: In pediatric caustic esophageal stricture, adjunctive topical MMC improves dysphagia resolution and reduces dilation burden. Multicentre RCTs with longer follow-up remain needed. PROSPERO REGISTRATION: CRD420261351544.